Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot of oral Sildenafil for Pulmonary Hypertension in Thalassaemia
2009-016096-29Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sildenafil in pulmonary hypertension (PH) and Thalassaemia (2 arms), sponsored by University College London. Primary endpoint: Change in Six Minute Walk Time (6MWT) distance at 12 weeks. Started Mar 2010; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)Thalassaemia
Beyond the preview
Go deeper on 2009-016096-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016096-29.